To validate observations from scRNA-Seq analysis of intratumoral CD45+ immune cells, we analyzed infiltrating immune cells in the early tumors and dLNs (10–14 days after inoculation) from tumor-bearing mice by flow cytometry (Supplemental Figure 10A). Here, PTPRC is linked to neoplasm.